financetom
Business
financetom
/
Business
/
Update: XPeng Shares Rise After Q1 Non-GAAP Loss Narrows, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: XPeng Shares Rise After Q1 Non-GAAP Loss Narrows, Revenue Increases
May 21, 2024 7:32 AM

10:14 AM EDT, 05/21/2024 (MT Newswires) -- (Updates with the latest stock price movement in the headline and first paragraph.)

XPeng ( XPEV ) shares were up nearly 13% in recent Tuesday trading after the company's Q1 non-GAAP loss narrowed year-over-year while revenue rose.

The company reported a Q1 non-GAAP net loss of 1.49 Chinese renminbi ($0.21) per diluted American depositary share, narrowing from the non-GAAP net loss of 2.57 renminbi per ADS a year earlier.

Three analysts polled by Capital IQ expected a non-GAAP net loss of 1.77 renminbi per ADS.

Revenue for the quarter ended March 31 was 6.55 billion renminbi, up from 4.03 billion renminbi a year earlier.

Four analysts polled by Capital IQ expected 6.41 billion renminbi.

The company said it expects Q2 revenue of 7.5 billion renminbi to 8.3 billion renminbi. Analysts polled by Capital IQ expect 10.65 billion renminbi.

Price: 9.35, Change: +1.07, Percent Change: +12.91

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Abbvie Insider Sold Shares Worth $10,539,508, According to a Recent SEC Filing
Abbvie Insider Sold Shares Worth $10,539,508, According to a Recent SEC Filing
Mar 21, 2024
10:43 AM EDT, 03/21/2024 (MT Newswires) -- Jeffrey Ryan Stewart, Executive Vice President, Chief Commercial Officer, on March 18, 2024, sold 58,949 shares in Abbvie ( ABBV ) for $10,539,508. Following the Form 4 filing with the SEC, Stewart has control over a total of 62,279 shares of the company, with 60,941 shares held directly and 1,338 controlled indirectly. SEC...
US FDIC draft proposal: bank mergers above $100 billion get extra scrutiny
US FDIC draft proposal: bank mergers above $100 billion get extra scrutiny
Mar 21, 2024
(Reuters) - Mergers that could result in banks with more than $100 billion in assets should expect heightened scrutiny from the U.S. Federal Deposit Insurance Corporation, according to draft guidance the agency released Thursday. The FDIC's board of directors is poised to vote on the proposal on Thursday. If adopted, the proposal would update the agency's merger guidance for the...
Corcept Therapeutics Insider Sold Shares Worth $430,475, According to a Recent SEC Filing
Corcept Therapeutics Insider Sold Shares Worth $430,475, According to a Recent SEC Filing
Mar 21, 2024
10:42 AM EDT, 03/21/2024 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on March 18, 2024, sold 17,219 shares in Corcept Therapeutics ( CORT ) for $430,475. Following the Form 4 filing with the SEC, Maduck has control over a total of 95,222 shares of the company, with 75,222 shares held directly and 20,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1088856/000095017024034264/xslF345X03/ownership.xml Price:...
Cencora Insider Sold Shares Worth $1,661,363, According to a Recent SEC Filing
Cencora Insider Sold Shares Worth $1,661,363, According to a Recent SEC Filing
Mar 21, 2024
10:43 AM EDT, 03/21/2024 (MT Newswires) -- Elizabeth S Campbell, Executive Vice President, on March 18, 2024, sold 6,977 shares in Cencora ( COR ) for $1,661,363. Following the Form 4 filing with the SEC, Campbell has control over a total of 8,246 shares of the company, with 8,246 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1140859/000114085924000056/xslF345X03/wk-form4_1710966227.xml Price: 242.08, Change: +0.21, Percent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved